238 related articles for article (PubMed ID: 2933041)
1. Slow calcium channel blockers and calmodulin. Effect of felodipine, nifedipine, prenylamine and bepridil on cardiac sarcolemmal calcium pumping ATPase.
Lamers JM; Cysouw KJ; Verdouw PD
Biochem Pharmacol; 1985 Nov; 34(21):3837-43. PubMed ID: 2933041
[TBL] [Abstract][Full Text] [Related]
2. The effects of felodipine and bepridil on calcium-stimulated calmodulin binding and calcium pumping ATPase of cardiac sarcolemma before and after removal of endogenous calmodulin.
Lamers JM; Verdouw PD; Mas-Oliva J
Mol Cell Biochem; 1987 Dec; 78(2):169-76. PubMed ID: 2964559
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of Ca2+-dependent protein kinase and Ca2+/Mg2+-ATPase in cardiac sarcolemma by the anti-calmodulin drug calmidazolium.
Lamers JM; Stinis JT
Cell Calcium; 1983 Oct; 4(4):281-94. PubMed ID: 6139171
[TBL] [Abstract][Full Text] [Related]
4. Bepridil and cetiedil. Vasodilators which inhibit Ca2+-dependent calmodulin interactions with erythrocyte membranes.
Agre P; Virshup D; Bennett V
J Clin Invest; 1984 Sep; 74(3):812-20. PubMed ID: 6088585
[TBL] [Abstract][Full Text] [Related]
5. Stimulation of canine cardiac sarcoplasmic reticulum Ca2+ uptake by dihydropyridine Ca2+ antagonists.
Movsesian MA; Ambudkar IS; Adelstein RS; Shamoo AE
Biochem Pharmacol; 1985 Jan; 34(2):195-201. PubMed ID: 3155615
[TBL] [Abstract][Full Text] [Related]
6. Effects of felodipine (a dihydropyridine calcium channel blocker) and analogues on calmodulin-dependent enzymes.
Walsh MP; Sutherland C; Scott-Woo GC
Biochem Pharmacol; 1988 Apr; 37(8):1569-80. PubMed ID: 2833901
[TBL] [Abstract][Full Text] [Related]
7. The binding of the calcium channel blocker, bepridil, to calmodulin.
Itoh H; Tanaka T; Mitani Y; Hidaka H
Biochem Pharmacol; 1986 Jan; 35(2):217-20. PubMed ID: 3484629
[TBL] [Abstract][Full Text] [Related]
8. Antagonism of calmodulin and phosphodiesterase by nifedipine and related calcium entry blockers.
Minocherhomjee AE; Roufogalis BD
Cell Calcium; 1984 Feb; 5(1):57-63. PubMed ID: 6325019
[TBL] [Abstract][Full Text] [Related]
9. Effects of verapamil, diltiazem, nisoldipine and felodipine on sarcoplasmic reticulum.
Wang T; Tsai LI; Schwartz A
Eur J Pharmacol; 1984 May; 100(3-4):253-61. PubMed ID: 6234179
[TBL] [Abstract][Full Text] [Related]
10. Differential actions of calcium antagonists on calcium binding to cardiac sarcolemma.
Pang DC; Sperelakis N
Eur J Pharmacol; 1982 Jul; 81(3):403-9. PubMed ID: 6981516
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of erythrocyte membrane Ca(2+)-pumping ATPase of hypertensive humans by nifedipine, a calcium entry blocker.
Olorunsogo OO; Onatola OO; Lawal SO; Bababunmi EA; Falase AO; Okunade WG
Afr J Med Med Sci; 1991 Mar; 20(1):61-5. PubMed ID: 1829316
[TBL] [Abstract][Full Text] [Related]
12. Bepridil and cetiedil reversibly inhibit thyroid hormone stimulation in vitro of human red cell Ca2+-ATPase activity.
Dube MP; Davis FB; Davis PJ; Blas SD
Mol Endocrinol; 1987 Feb; 1(2):168-71. PubMed ID: 2970587
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of sodium-calcium exchange in cardiac sarcolemmal membrane vesicles. 2. Mechanism of inhibition by bepridil.
Garcia ML; Slaughter RS; King VF; Kaczorowski GJ
Biochemistry; 1988 Apr; 27(7):2410-5. PubMed ID: 3260109
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of turkey gizzard myosin light chain. Kinase activity by dihydropyridine calcium antagonists.
Movsesian MA; Swain AL; Adelstein RS
Biochem Pharmacol; 1984 Dec; 33(23):3759-64. PubMed ID: 6548915
[TBL] [Abstract][Full Text] [Related]
15. Amiodarone is a potent calmodulin antagonist.
Nokin P; Blondiaux JP; Schaeffer P; Jungbluth L; Lugnier C
Naunyn Schmiedebergs Arch Pharmacol; 1989 Apr; 339(4):367-73. PubMed ID: 2544810
[TBL] [Abstract][Full Text] [Related]
16. Kinetic characterization of the Ca2+-pumping ATPase of cardia sarcolemma in four states of activation.
Dixon DA; Haynes DH
J Biol Chem; 1989 Aug; 264(23):13612-22. PubMed ID: 2527231
[TBL] [Abstract][Full Text] [Related]
17. Calcium channel blocker inhibition of the calmodulin-dependent effects of thyroid hormone and milrinone on rabbit myocardial membrane Ca2+-ATPase activity.
Warnick PR; Davis FB; Mylotte KM; Davis PJ; Dube MP; Blas SD
Biochem Pharmacol; 1988 Jul; 37(13):2619-23. PubMed ID: 2968801
[TBL] [Abstract][Full Text] [Related]
18. Cooperativity among calmodulin's drug binding sites.
Mills JS; Bailey BL; Johnson JD
Biochemistry; 1985 Aug; 24(18):4897-902. PubMed ID: 4074665
[TBL] [Abstract][Full Text] [Related]
19. Differences in Ca2+ entry blockers revealed by effects on adenosine- and adrenergic- receptors and cyclic AMP levels of [2-3H]adenine-prelabeled vesicles prepared from guinea pig brain.
Psychoyos S; Bax M; Atkins C
Biochem Pharmacol; 1986 May; 35(10):1639-46. PubMed ID: 3011009
[TBL] [Abstract][Full Text] [Related]
20. Calcium transport systems in cardiac sarcolemma and their regulation by the second messengers cyclic AMP and calcium-calmodulin.
Lamers JM
Gen Physiol Biophys; 1985 Apr; 4(2):143-54. PubMed ID: 2993098
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
